PARSIPPANY, N.J., April 18, 2018 -- Ogilvy CommonHealth Worldwide (www.ogilvychww.com), a WPP Health & Wellness company (NYSE:WPP) (www.wpp.com), today announced Catherine Goss, SVP, managing director, and Ashli Sherman, VP, client services, have been selected to present at the 18th Annual DTC National Conference on April 19 in Boston, Massachusetts.
Ms. Goss and Ms. Sherman will co-present their session, titled Supporting the Patient Experience Track: DTC for Cancer Treatments: Must-See TV. Their presentation will explore the impact of today’s DTC efforts and help identify information gaps by sharing ethnography clips of conversations between real patients and their doctors within the context of actual office visits. Ms. Goss and Ms. Sherman will also discuss ideas about what brands should include in their marketing efforts to better educate and support patients during this difficult journey.
Organized by DTC Perspectives, a publishing, conference/training, and consulting company specializing in the area of consumer marketing of pharmaceutical and healthcare products, the DTC National Conference provides the latest insights, research and case studies on all aspects of DTC pharmaceutical marketing. For more information, please visit: http://dtcperspectives.com/dtcn/.
About Ogilvy CommonHealth Worldwide
Ogilvy CommonHealth Worldwide, a WPP Health & Wellness company, is committed to creativity and effectiveness in healthcare communications, everywhere. Our global headquarters are in Parsippany, New Jersey, with additional hubs in New York, London, Paris, and Singapore. We maintain multiple additional offices in markets critical to our clients’ global aspirations. Ogilvy CommonHealth Worldwide provides marketing services, including behavioral insights, content strategy and management, digital, interactive and new media services, marketing analytics and research, media planning and buying, medical education, payer marketing and market access, professional advertising and promotion, public affairs and relations, relationship marketing, sales training development, scientific communications, social media and social listening, and wellness and consumer advertising and promotion. The organization houses and maintains individual Ogilvy CommonHealth and Ogilvy Healthworld brand identities within the marketplace.
Contact:
Beth Paulino or
Kerianne Slattery
Ogilvy CommonHealth Worldwide
973.352.1000 tel


More U.S. Investors Join Arbitration Against South Korea Over Coupang Dispute
Anduril Eyes $60 Billion Valuation in New Funding Round to Expand Defense Manufacturing and Autonomous Fighter Jet Development
GE Aerospace Expands Singapore Engine Repair Hub with Automation and AI to Tackle Aviation Bottlenecks
Valero Energy Expands Venezuelan Crude Imports as U.S. Sanctions Ease
Sachem Head Boosts Warner Bros. Discovery Stake Amid Netflix Deal and Paramount Bid
ByteDance Advances AI Chip Development With Samsung Manufacturing Talks
U.S. Judge Allows Jeffrey Epstein Sex Trafficking Lawsuit Against Bank of America to Proceed
Spirit Airlines Seeks Court Approval to Auction 20 Airbus A320/A321 Aircraft Amid Bankruptcy
FTC Questions Apple News Over Alleged Bias Against Conservative Media
Vale Reports $3.8 Billion Q4 Net Loss Amid Nickel Asset Impairment and Samarco Provisions
Instagram CEO Defends Platform in Youth Mental Health Lawsuit Over Social Media Addiction Claims
ANZ Shares Hit Record High After Strong Q1 Profit and Cost-Cutting Gains
Xiaomi EV Deliveries Surpass 600,000 Units as SU7 and YU7 Drive Strong Growth
Novartis’ Vanrafia Shows Strong Phase 3 Results in IgA Nephropathy, Paving Way for Full Approval
Novocure Stock Surges 30% After FDA Approves Optune Pax for Pancreatic Cancer Treatment
Westpac (ASX: WBC) Q1 Profit Rises 6% as Lending Growth and Treasury Income Strengthen Earnings 



